Aimmune Therapeutics, Inc.

Hudson Bay Capital Management LP

Report date

9/30/2020

Quarter

2020 Q3

Filed

11/12/2020

Shares

116,700

Value ($000)

4,020

Weight

0.1%

2019 Q4 - 2020 Q3 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q3	11/12/2020	4,020	0.1%	116,700	9/30/2020
2020 Q2	8/12/2020	11,195	0.2%	670,000	6/30/2020
2020 Q1	5/14/2020	9,888	0.3%	685,716	3/31/2020
2019 Q4	2/12/2020	9,204	0.2%	275,000	12/31/2019